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Abstract. Kruppel-like factors (KLFs) are a family
of seventeen proteins designated KLF1 to KLF17.
KLFs are transcriptional factors that bind GC-rich
sequences such as CACCC elements. The DNA binds
to KLFs via three carboxyl-terminal Cys-2/His-2 zinc
fingers. KLFs control cell differentiation and embryonic
development. They are also implicated in a number of
cellular functions such as erythropoiesis, proliferation
and tissue development. This review will focus primar-
ily on KLFs that are involved in haemoglobin control.
These include KLF1, KLF2, KLF3, KLF8 and KLF10.
The connection between human KLF1 and elevated
foetal haemoglobin was first identified in a study
done by (Borg et al., 2011) on a large Maltese family
with Hereditary Persistence of Foetal Haemoglobin
(HPFH) where a nonsense mutation in the Erythroid
Kruppel-Like Factor 1 gene (KLF1 ) was identified as
the main cause of HPFH. KLF2 is a positive regulator
of mouse and human embryonic B-globin genes and
it overlaps with KLF1 in embryonic erythropoiesis.
KLF3 and KLF8 expression is driven by KLF1 while
together KLF3 and KLF8 participate in the silencing
of embyronic globin expression during development.
KLF10 expression was also shown to be associated
with high foetal haemoglobin levels in Bthalassaemia
patients undergoing hydroxyurea treatment.
Keywords Haemoglobinb - Kruppel-like factor 1 - B-
thalassaemia - Erythropoiesis.
Correspondence to: J. Borg (joseph.borg@biotech.um.edu.mt)
c© 2014 Xjenza Online
1 Introduction
The study of haemoglobin (Hb) switching in humans
has provided a focus in haematology due in large part
to fundamental importance of gene switching in human
biology and the clinical significance of the foetal to adult
globin switch for developing targeted methodologies to
for the treatment of the B-type haemoglobin maladies
such as thalassaemia and sickle cell disease (Orkin and
Higgs, 2010). Hb is constituted of two α-like and two B-
like globin chains, encoded by genes in the HBA and
HBB loci, respectively. Developmental regulation of
globin genes results in expression of stage-specific Hb
molecules.
Figure 1: Developmental Globin Chain Synthesis. The
timeline of the expression of the human globin genes is shown
on the X-axis.
2 Developmental Control of
Globin Gene Expression
The exact nature of globin gene switching from Gto Bis
still largely unknown and it is through very specific ques-
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tions that one is able to answer parts of this occurrence.
Hereditary persistence of foetal haemoglobin (HPFH)
has been long sought as a useful contributory ‘condi-
tion’ that can yield additional information on how foetal
haemoglobin (Hb F) is regulated and controlled in vivo
at the adult stage. Hb F ameliorates the symptoms of
B-thalassaemia and sickle cell disease (SCD), and reac-
tivation of the HBG1/HBG2 genes in adults is there-
fore of substantial interest for the clinical management
of B-type haemoglobin disorders. During the develop-
ment of the human body, seven normal haemoglobin
types are expressed in developmental pattern. The pro-
duction of normal haemoglobin is characterized by two
switches (Fig. 1). These are, the embryonic to foetal
haemoglobin switch and the foetal to adult haemoglobin
switch, the latter being the subject of many critical
questions and reviews (Bank, 2006). The embryonic
haemoglobin is composed of Hb Gower 1 (α2E2), Hb
Gower 2 (ζ2E2) and Hb Portland (ζ2G2). As the expres-
sion of ζ- and E- globin begins to cease after the first two
months of gestation, the first haemoglobin switch occurs
giving rise to the synthesis of HbF (α2GG2) and (α2AG2).
The site of erythropoiesis also changes from the yolk
sac and para-aortic region to the foetal liver (Dover
and Boyer, 1980). HbF has a higher oxygen affinity
since it binds 2,3-bisphosphoglyceric acid (2,3-BGP) less
strongly predominates in the last two trimesters of ges-
tation before the second globin switch takes place (For-
get, 1998). The second globin switch which occurs at
the time of birth, involves the decline of HbF synthesis
coupled with increased synthesis of adult haemoglobin
composed of HbA (α2B2) with a minor HbA2 (α2δ2)
(Brinkman and Jonxis, 1935; Weinberg et al., 1983).
This switch is also accompanied by a change in the site
of erythropoiesis from the foetal liver and spleen to the
bone marrow. However, the anatomical transitions are
not thought to be the cause of the gene switching events.
Residual amounts of Hb F continue to be synthesized
throughout adult life and expressed by F-erythrocytes
(Hosoi, ; Stamatoyannopoulus and Grosveld, 2001). In
the majority of adults, Hb F consists of less than 2%
to total Hb, but there is considerable variation (Thein
et al., 2009). Genetic studies have revealed at least
three loci that could control Hb F levels in adults: HBB
(11p15.4) (Gilman and Huisman, 1985; Craig et al.,
1996), HBS1L-MYB (6q23.3) (Close et al., 2004; Craig
et al., 1996; Garner et al., 1998) and BCL11A (2p16.1)
(Menzel et al., 2007; Lettre et al., 2008). Together,
these loci account for less than 50% of the variation in
Hb F, indicating that additional loci may be involved.
The HBB locus in particular contains an important pro-
moter sequence variation at position -158 five primer (5’)
to the GGglobin gene, called Xmn1 site and other globin
gene rearrangements (such as GG- GG, AG- AGor multi-
ple Gglobin genes) that have shown to effect Hb F levels
and GG:AGratios in normal individuals and/or individ-
uals with anaemic stress (Thein et al., 2009).
Clinical syndromes such as the B-thalassaemias, hered-
itary persistence of foetal haemoglobin (HPFH) and δB-
thalassaemias have all proved to be unique clinical mod-
els underlying the pathophysiology of globin gene ex-
pression and control in haemoglobinopathies. Genetic
analysis of HPFH families is a particularly powerful ap-
proach to identify novel modifiers of Hb F levels (Close
et al., 2004).
Indeed early clues (Weatherall and Clegg, 1975; Huis-
man et al., 1975) had indicated that important DNA
regulatory sequences are present in between the foetal
Gglobin genes and adult Bglobin genes. The various
types of Gglobin gene re-arrangements and deletional
HPFH encompassing DNA regions of the AG-δintergenic
region characterized this. A poly-pyrimidine rich re-
gion (PYR) is located in this intergenic region and at-
tracts numerous protein complexes that together form
a repressor-like complex that silences the foetal Gglobin
genes (Bank, 2006). A subset of important and criti-
cal genes that act in concert with other molecules and
bring about control and regulation of haemoglobin are
the Kruppel-like factor genes, most notably Kruppel-
like factor 1 (KLF1), Kruppel-like factor 3 (KLF3) and
Kruppel-like factor 10 (KLF10).
Figure 2: Schematic diagram of the KLF1 molecule. The
three C-terminal C2H2 zinc fingers are shown, each chelating a
single zinc ion. The fingers are linked together by “TGERP”-
like motif, which assists in binding to target DNA. The activa-
tion/repression domain is found at the N-terminus of the molecule
(Adapted from (Pearson et al., 2011))
3 Kruppel-like factor 1
Kruppel-like factors are a subset of genes that code
for transcription factors designated KLF1 to KLF17
important in transcriptional regulation and control of a
number of other genes. KLFs are implicated in many
cellular functions such as erythropoiesis, cell differenti-
ation, proliferation and tissue development (McConnell
and Yang, 2010). A closely-knit network of KLFs
interacts together to regulate the switch from foetal to
adult haemoglobin. A duplicated CACCC sequence,
known to attract and bind Kruppel-like factors, in the
B-globin gene is located between -90 to -105 and is also
present in the Eand Ggenes (Nienhuis and Maniatis,
1987). The α-globin gene promoter (Liebhaber et al.,
1980) also comprises a CACCC similar sequence box
of the B-globin promoter at position -84 to -89. The
CACCC -box sequences (CCACACCCT ) (Donze et al.,
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1995) are frequently found in erythroid-specific gene
promoters. Two such sites are present in the human
and mouse B-globin promoters. KLF1 (Figure 2) is
active in primitive and definitive haematopoiesis and
not required for yolk sac erythropoiesis and erythroid
commitment (Nuez et al., 1995; Perkins et al., 1995),
suggested that it is important for the transition from
foetal to adult globin expression in humans. Addition-
ally, single base substitutions in the KLF1 binding sites
in the B-globin gene promoter cause B-thalassaemia
(Orkin et al., 1982). (Schoenfelder et al., 2010) found
that mouse Hbb and Hba associate with hundreds of
active genes from nearly all chromosomes in nuclear foci
known as ‘transcription factories’. The 2-globin genes
preferentially associated with a specific and partially
overlapping subset of active genes. (Schoenfelder et al.,
2010) also noted that expression of the Hbb locus is
strongly dependent upon KLF1, while expression of
the Hba locus is only partially dependent on KLF1.
Immunofluorescence examination of mouse erythroid
cells displayed that most KLF1 concentrated to the
cytoplasm and that nuclear KLF1 was present in iso-
lated sites as clusters. Erythroid cells from KLF1 null
mice specifically showed a disruption of the association
of KLF1- regulated genes within the Hbb-associated
network. KLF1 knockout more insipidly disrupted
interactions within the specific Hba network. (Schoen-
felder et al., 2010) revealed that KLF1-regulated genes
share KLF1-containing transcription factories and that
KLF1 is required for the clustering of these co-regulated
genes. It was suggested that transcriptional regulation
involves a complex 3-dimensional network rather than
factors acting on single genes in isolation.
The description of the Active Chromatin Hub (ACH)
gave a 3D picture of the human and mouse B-globin loci
(Tolhuis et al., 2002; Palstra et al., 2003; Patrinos et al.,
2004) and revealed a dynamic structure that commu-
nicates enhancers, promoters and specific regulators
and co-regulators to execute gene transcription. In this
model, the intervening sequences and non-transcribed
genes are looping out of the active site of transcription,
supporting a looping model for transcriptional activa-
tion of the globin genes.
The first transcription regulator that was shown to
influence the formation of the ACH to execute correct
expression of genes found within the B-globin locus
was KLF1. In the absence of KLF1, a fully functional
ACH cannot be formed (Drissen et al., 2004). Together
with the observation that in KLF1 knockout mice loss
of 5’HS3 and Bmaj-promoter chromatin accessibility
(Wijgerde et al., 1996) occurs, this implied that
KLF1 is crucial for hypersensitive site formation and
involvement of the Locus Control Region (LCR) and
the B-globin promoter in the ACH, possibly through
interactions with a SWI/SNF chromatin remodeling
complex (Armstrong and Emerson, 1998). GATA1 was
also shown to be essential for LCR-gene contacts (Vakoc
et al., 2005) in contrast with Ctcf that was found to
be dispensable for such interactions and globin gene
expression (Splinter et al., 2006). A conceivable role of
the LCR loop formation in RNAPolII loading to the
promoters of the globin genes has been proposed (John-
son et al., 2001). Still, in KLF1 knockout erythrocytes,
RNAPolII is loaded on the promoter of B-globin but the
levels of Ser2 phosphorylated PolII, as a mark of active
transcription, are reduced. This explains the decrease
in B-globin expression (Bottardi et al., 2006). Thus, it is
more likely that the recruitment of RNAPolII, at least
to the B- globin promoter, is LCR independent while
the transition from the initiation to the elongation
step of active transcription is KLF1-dependent LCR
formation (Sawado et al., 2003).
Mutations in human KLF1 were first reported by
(Singleton et al., 2008) where it was found that 9
different loss-of-function KLF1 mutations were re-
sponsible for a rare In(Lu) blood group. One of the
mutations results in a loss of 1 of 3 possible GATA1
binding sites in the human KLF promoter. The other
8 different mutations were found in the KLF1 coding
sequence. The effect of these mutations considerably
overlapped with those reported in KLF1 null mouse
studies (Drissen et al., 2005; Hodge et al., 2006; Pilon
et al., 2008). These mutations resulted in individuals
with a slightly elevated HbF (1-3%) and their red cells
showed gross reduction in expression of Lutheran blood
group glycoprotein together with a reduction in Cluster
of Differentiation (CD)44 (Singleton et al., 2008).
Figure 3: Model for the regulation of B-like globin expres-
sion by KLF1 in adults. Figure a shows that KLF1 preferen-
tially activates the HBB gene and the BCL11A gene, while the
BCL11A protein silences the HBG1/HBG2 (HBG) genes in nor-
mal adults. Figure b shows that in patients with KLF1 p.K288X
mutation KLF1 activity is reduced. This decreases expression of
BCL11A and the diminished amount of BCL11A protein allevi-
ates repression of the HBG1/HBG2 genes. Adapted from Hap-
loinsufficiency for the erythroid transcription factor KLF1 causes
Hereditary Persistence of Foetal Haemoglobin, by (Borg et al.,
2010).
The role of in vivo KLF1 in elevated HbF and control
of human haemoglobin switching was shown for the first
time in a large Maltese family (Borg et al., 2010). Ten
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out of twenty seven family members exhibited Hered-
itary Persistence of Foetal Haemoglobin (HPFH) with
HbF levels ranging from 3.3% to 19.5%. A genome wide
linkage analysis on the 27 family members revealed a
consistent haplotype at 19p13.12-13 co-segregating with
the high HbF. DNA sequencing reveled two linked mu-
tations in KLF1 that were found in all individuals with
HPFH. The first mutation was inferred to be a neu-
tral substitution (p.M39L), as mouse KLF1 contains a
leucine at this position (Miller and Bieker, 1993). The
second mutation is the p.K288X mutation, heterozy-
gous nonsense mutation that involves an alanine (A)
to thymine (T) transversion resulting in a lys288-to-
ter (K288X) premature stop codon. This mutation is
predicated to ablate the complete zinc finger domain of
the protein (Feng et al., 1994), perturbing its function.
A random sample of 400 individuals drawn from the
general Maltese population did not find KLF1 p.K288X
variant. A genome wide expression analysis was car-
ried out on RNA isolated from erythroid progenitors
cultured from peripheral blood from four family mem-
bers with HPFH and four without. These data showed
that mild hypochromic microcytic indices shown by in-
dividuals with HPFH was due to deregulation of these
KLF1 target genes. It was also noted that embryonic
Hbb-y and HBE1 genes were highly regulated whereas
the expression of BCL11A was downregulated in these
HPFH individuals. BCL11A is a foetal globin repres-
sor (Sankaran et al., 2008). Downregulation of BCL11A
and expression of HBG1/HBG2 genes was confirmed
by quantitative RT-PCR (qPCR). KLF1 knockdown in
human erythroid progenitor cells (HEPs) derived from
healthy donors was investigated and the quantitative S1
nuclease protection assays showed that knockdown of
KLF1 give rise to an increase in HBG1/HBG2 expres-
sion and also a decrease in BLC11A expression both at a
protein level and at mRNA level. HEPs were transduced
with lentiviral vectors that expressed either the KLF1
p.K288X truncation mutant or full length KLF1. After
transduction with full length KLF1, levels of BCL11A
protein were increased. This result was not observed af-
ter transduction with either Green Fluorescent Protein
(GFP) or truncated KLF1 lentiviral vectors. This shows
that KLF has a dual role (Figure 3) in the regulation of
foetal-to-adult globin gene switching. Primarily it acts
directly on the HBB locus as a preferential activator of
the HBB gene as reported by (Wijgerde et al., 1996) and
secondly it acts indirectly by activating the expression
of BCL11A which in turns represses the HBG1/HBG2
genes (Borg et al., 2010; Zhou et al., 2010). In this study
it was concluded that haploinsufficiency of KLF1 give
rise to HPFH and a fruitful approach in raising HbF
levels in individuals with B-type haemoglobinopathies
can be achieved by the attenuation of KLF1.
When compared to primitive erythroid progenitors,
in definitive erythroid progenitors it was shown that the
level of mouse KLF1 increases threefold (Zhou et al.,
2006). When carrying out chromatin immunoprecipita-
tion (CHIP) experiments, it was found that this tempo-
ral change in KLF1 abundance is due to the differential
binding of KLF1 to embryonic/foetal and adult globin
gene promoters during development (Zhou et al., 2010).
To study the hypothesis that a decrease in KLF1 levels
in adult erythroid progenitors will give rise in reactiva-
tion of foetal globin gene expression (Zhou et al., 2010)
deleted the 50-base pair HS1 enhancer of the mouse
KLF1 gene and the mutant allele strain was bred with
mice containing a bacterial artificial chromosome carry-
ing a 100-kb insert spanning the human globin locus.
It was found that there was an increase in endogenous
mouse EG2-globin/B-globin and BAC derived human G-
globin/B-globin gene expression ratios in livers of em-
bryonic (E) 14.5 animals that were homozygous for the
enhancer deletion. It showed that an increase in defini-
tive erythroid progenitors is essential for correct globin
gene switching.
The BCL11A RNA and BLC11A protein levels
were examined in adult erythroid progenitors from
KLF1EHS1∆/EHS1∆ mice and it was found as already
concluded by (Borg et al., 2010) that Bcl11a expres-
sion is decreased, which in turn augments G-globin gene
expression. When carrying out Chip-quantitative PCR
(qPCR), (Zhou et al., 2010) found that in adult bone
marrow erythroid cells, KLF1 binds to the CACCC box
in the mouse BCL11A promoter, whilst (Borg et al.,
2010) showed the same in humans. Therefore BCL11A
expression is directly regulated by KLF1 in vivo.
4 KLF1 mutations and
Haemoglobin A2
One of the most reliable haematological findings for
identification of B-thalassaemia carriers is increased
haemoglobin A2 (HbA2) between 3.8% to 6.0%.
This is not always the case because some atypi-
cal carriers have borderline HbA2 levels those be-
tween 3.3% - 3.8% (Galanello et al., 1994; Mosca
et al., 2008; Giambona et al., 2008). Decreased
mean corpuscular volume (MCV) and mean corpuscular
haemoglobin (MCH) are usually associated with bor-
derline A2 levels and these are usually the result of
mild B+ -thalassaemia mutations, co-inherited δand B-
thalassaemia, B-promoter mutations or coexisting iron
deficiency anaemia (Harthoorn-Lasthuizen et al., 1999;
Galanello et al., 1981). Genetic determinants such as
triplication of the α-globin genes, B-promoter mutations
and some HBD and HBB gene variants can give rise
to borderline HbA2 with normal MCV and MCH %
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(Galanello et al., 1994; Mosca et al., 2008; Giambona
et al., 2008). (Perseu et al., 2011) for the first time
found that KLF1 gene mutations are responsible for in-
dividuals with border line HbA2 and normal MCV and
MCH.
In this study 145 subjects with borderline HbA2 (val-
ues between 3.3% and 4.1%) and normal or slightly
reduced MCV and MCH were studied while 8 nor-
mal people were used as controls. The presence of
mutations in the HBB promoter, triplicated α-globin
genes, and haemoglobin variants were excluded. Out
of the 145 subjects, 52 had the non-sense KLF1
p.Ser270X mutation, similar to the one reported by
(Borg et al., 2010) but slightly more upstream. The
p.Thr280 His283del mutation was found in two sub-
jects while the p.Arg319GlufsX34 frameshift mutation
was found in four individuals. Two individuals had
the p.Thr327Ser mutation while one individual had
the p.Lys332Gln missense mutation; another one had
the p.Leu326Arg mutation. The p.Ser270X muta-
tion and the Thr280 His283 del mutation lie in exon
2 and 4, while the p.Arg319GlufsX34, p.Leu326Arg,
p.Thr327Ser and p.Lys332Gln lie in exon 3. The
p.Ser270X and the p.Arg319GlufsX34 mutations result
in haploinsufficiency of KLF1 since they ablate the DNA
binding domain. On the other hand the p.Thr280 -
His283del mutation result in the deletion of cysteine
281 which is crucial for Zn coordination and therefore it
eliminates the Zn finger structure and binding to DNA.
The other missense mutations that is the p.Leu326Arg,
p.Thr327Ser and the p.Lys332Gln mutations affects the
amino acids that are adjacent to the residues expected
to directly contact DNA. Therefore this might interfere
with the binding of KLF1 to DNA. On the other hand
these mutations could impair the interaction of KLF1
with Brg1 and Baf156 that were mapped by (Kadam
et al., 2000) to the DNA binding domain resulting in the
alteration of the chromatin remodeling ability of KLF1.
In the 145 subjects no correlation between HbF levels
and known HbF-associated polymorphisms such as the
XmnI in the HBG1 gene, rs9399137 in the HBSIL-MYB
intergenic region and the rs11886868 in the BCL11A
gene was found (Thein et al., 2007; Uda et al., 2008).
As previously reported by (Singleton et al., 2008; Borg
et al., 2010; Satta et al., 2011) in large series of subjects
anaemia was absent in individuals carrying KLF1 muta-
tions. This confirms that one functional KLF1 allele is
sufficient to sustain normal human erythropoiesis. Also
all the KLF1 mutations were associated with the In(Lu)
blood group as reported by (Singleton et al., 2008). This
suggests that the amount of KLF1 necessary to regulate
Lutheran expression is highly limiting.
5 KLF1 mutations and Foetal
Haemoglobin
HPFH is characterized by the presence of elevated foetal
haemoglobin in red blood cells of adults. Individuals
may be heterozygotes, homozygotes or compound het-
erozygotes for HPFH (Huisman et al., 1975) and it has
been identified in a diverse range of ethnic groups (Gia-
rdine et al., 2007). It is well known that HPFH can be
caused by deletions within the B-globin gene cluster on
chromosome 11 (Henthorn et al., 1990) and point muta-
tions in the promoters of the G-globin genes (Ottolenghi
et al., 1989; Wood, 1993). Single nucleotide polymor-
phisms (SNPs) or oligonuclotide motifs within the B-
globin gene cluster are also associated with HPFH. The
C-T polymorphism at position -158 of the G-Gpromoter
which creates an Xmn1 restriction site is the best know
of these mutations (Gilman and Huisman, 1985). As
already mentioned two major sites that affect the HbF
levels that are unlinked to the B-globin gene cluster that
have been identified are the HBS1L-MYB intergenic
region on chromosome 6q23 (Thein et al., 2007) and
the BCL11A on chromosome 2p16.1 (Uda et al., 2008).
An addition potential locus associated with HPFH was
identified by (Borg et al., 2010) and this was the KLF1
gene.
To examine whether KLF1 mutations are involved in
the increased HbF levels a study by (Gallienne et al.,
2011) was carried out. In this study a total of 131
samples with elevated HbF levels (between 1.5-25%) to-
gether with 121 normal samples with HbF levels < 1%
were tested for KLF1 mutations. Out of 131 patients,
41 were α-thalassaemia carriers, one had Haemoglobin
E disease, 6 were carriers for sickle cell trait and 28
were carriers for a B-thalassaemia mutation. In to-
tal in these 131 subjects, eleven different KLF1 mu-
tations were identified, nine of which were previously
unreported. A polyPhen-2 and SIFT analysis for the
mutations in KLF1 identified in 11 out of these 131
subjects predicted to effect gene function. Eight of the
eleven mutations were missense mutations. The p.L51R
was in exon 1 while p.R301C, R301H, W313C, R328H,
R328L, T334K and T334R are in the zinc finger do-
mains. These mutations are expected to disrupt DNA
binding. In exon 2, two frame shift mutations were
found while an 11 bp deletion, the K54PfxX9, mutation
gave rise to new stop codon 8 nucleotides downstream.
This mutation is the most severe type of mutation since
it gives rise to the loss of all three zinc finger domains
and most of exon 2. A G176AfsX179 gave rise to a
7bp insertion producing a stop codon 178 nucleotides
downstream. The final mutation identified was a 1 bp
nucleotide substitution at the 3’ end of exon 2. This
mutation is expected to disrupt splicing. In one of the
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individuals homozygote for sickle cell mutation a previ-
ously unreported KLF1 mutation was identified. This
mutation was the c.914-4 -14-1 del CTAG. This indi-
vidual was completely asymptomatic and maintained a
haemoglobin level of 12.7g/dL with HbF level of 20.3%.
This shows that the KLF1 mutation is ameliorating the
phenotype by increasing the HbF level via reduced G-
globin gene suppression.
KLF1 mutations are associated with a spectrum of
phenotypes such as the In(Lu)blood group (Single-
ton et al., 2008), zinc protoporphyria (Satta et al.,
2011), Increased HbA2 (Perseu et al., 2011), congen-
ital dyserythropoeitic anaemia (CDA) (Arnaud et al.,
2010) and hereditary persistence of foetal haemoglobin
(Borg et al., 2010).
6 Kruppel-like factor 10
(KLF10)
KLF10 is situated on chromosome 8q22.2 and functions
as a transcriptional repressor involved in the regulation
of cell growth. Whole-transcriptome analysis identified
molecular signatures of HEP cells isolated from two pa-
tient groups representing B-thalassaemia and SCD pa-
tients that respond well or do not respond well to Hy-
droxyurea (HU) treatments, and a healthy adult group
whose erythroid progenitor cells were grown with or
without addition of HU in culture media (Borg et al.,
2011). Looking at molecular signatures in response to
HU common probe sets revealed 43 common genes that
may be involved in developmental regulation of HbF.
These genes can act either directly or indirectly leading
to an increase in G-globin synthesis therefore an increase
in HbF.
One HU target gene of particular interest that was
present in all groups was the KLF10 gene. The KLF10
gene appeared to be significantly associated with high
HbF because it appeared in the comparison between
low- versus high HbF expressing cells under HU treat-
ment for both the Hellenic B-thalassaemia/SCD com-
pound heterozygotes and the Maltese individuals. It
appears that KLF10 is both an HU and a KLF1 tar-
get; it appears to influence globin synthesis by act-
ing on genes either directly or indirectly. In the Cau-
casian populations, within KLF10 four tag SNPs with
a minor allele frequency were identified. Two of the
SNPs reside in the 3-Untranslated Region (UTR), one
is a synonymous-coding SNP in exon 3 and one is in-
tronic. The intronic, SNP namely the rs3191333 poly-
morphism resides on a regulatory region and therefore
it can act as a pharmacogenomic marker by exerting a
functional role of KLF10 expression. To see the effect
of rs3191333 (c.*141C>T) tag SNP with B-thalassaemia
severity (Borg et al., 2011) exploited a large number of
B-thalassaemia major patients with low HbF and well-
characterized B-thalassaemia intermedia patients with
high HbF levels. An independent B-thalassaemia/SCD
compound heterozygous patient sample that received
HU as therapeutic routine also was included. It was
concluded that the absence of the rare homozygous mu-
tant (TT) SNP (rs3191333) is significantly associated
with increased HbF in B-thalassaemia intermedia com-
pared with B-thalassaemia major patients and healthy
volunteers. In B-thalassaemia intermedia samples the
rare allele (T) is less frequent and only present in het-
erozygous state. Therefore it can be hypothesized that
the presence of the T allele in context of B-thalassaemia
could be associated with low HbF levels. An inverse
correlation in the homozygous normal C/C in respon-
ders and homozygous T/T genotypes in non responders
was also noted. From the above one can conclude that
in homozygous mutant state the rs3131333 SNP renders
the KLF10 transcript unstable and therefore the KLF10
gene expression is decreased.
It has been hypothesized that the KLF10 might be
acting through SIN3A, especially since the interactions
between the two have been already documented by
(Zhang et al., 2001). The SIN3A is a very important
corepressor gene that works together with HDAC1 and
physically binds to KLF1 on acetylated lysine residue at
position 302 and in turn this represses KLF1 activity.
Repressed activity of KLF1 results in decreased adult
stage globin synthesis which in turn facilitates the syn-
thesis of foetal globin (Siatecka and Bieker, 2011). It
can be hypothesized that though the interaction with
SIN3A, KLF10 represses the adult HBB gene leading to
a higher HBF level (Borg et al., 2011).
7 Kruppel-like factor 2 (KLF2)
KLF2 is a positive regulator of the mouse and human
embryonic B-globin genes (Basu et al., 2005). KLF2
was known as lung KLF or LKLF and plays an impor-
tant role in T-cell differentiation and blood vessel de-
velopment (McConnell and Yang, 2010). Within their
DNA binding domains, KLF1 and KLF2 have high ho-
mology and they reside close to each other on chromo-
some 19 in human and on chromosome 8 in mouse (Basu
et al., 2005). In mouse embryonic B-globin genes, KLF1
and KLF2 can partially compensate for each other. It
was found that when both KLF1 and KLF2 are ablated
in mice, there is more reduction in EGand Bh1-globin
mRNA than when KLF1 or KLF2 single knockdowns
are performed (Basu et al., 2007).
(Alhashem et al., 2011) determined whether KLF1
and KLF2 control the human embryonic and foetal B-
globin genes and the mechanistic roles of these two
genes in globin gene regulation. For this study a
mouse model that has the KLF1 and KLF2 knock
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out (KO) alleles on the same DNA homology was
generated together with transgenic (Tg) mice that
carry the entire human B-globin locus. The Tg-HBB
mice were bred with KLF1+/− or KLF2+/− mice
and therefore KLF1+/−Tg-HBB KLF2+/−Tg-HBB and
KLF1+/−KLF2+/−Tg-HBB mice were obtained. The
mouse embryonic yolk sacs and blood cells were collected
followed by RNA and cDNA synthesis and ChIP assays.
By comparing the amounts of KLF1 and KLF2 mRNA
it was found that the quantities of KLF1 equalled the
KLF2 mRNA at E9.5 but KLF1 mRNA increases dra-
matically by E12.5 whereas KLF2 mRNA levels remain
relatively unchanged between E9.5 and E12.5. This
shows that at E9.5 both KLF1 and KLF2 regulate the
mouse EGand Bh1-globin genes but at E12.5 only KLF1
regulates adult B-globin gene expression.
It was already known by (Basu et al., 2007) that
KLF1 and KLF2 regulate the mouse embryonic EGand
Bh1 during primitive erythropoiesis, (Alhashem et al.,
2011) wanted to test whether these two genes also reg-
ulate human B-globin gene expression in embryo. In
transgenic mouse models, the human embryonic and
foetal B-globin genes, the Eand Gare both expressed
at E10.5 (Jiang et al., 2008). To test this hypothesis
dual Tg-HBB and heterozygous KO mice were crossed
with heterozygous KO mice to obtain E10.5 KLF1-/-Tg-
HBB, KLF2-/-Tg-HBB and KLF1-/-KLF2-/-Tg-HBB
embryos. The amounts of human E- and G- globin
mRNA was measured using qRT-PCR. It was found
that E-globin mRNA was significantly reduced to 15 to
49% in KLF1-/-Tg-HBB and KLF2-/-Tg-HBB yolk sacs
when compared with Tg-HBB. On the hand G-globin
mRNA was reduced to 31% of Tg-HBB in KLF1-/-Tg-
HBB yolk sacs. In KLF2-/-Tg-HBB yolk sacs the G-
globin gene expression is reduced to 73% showing that
KLF2 has a more modest effect on G-globin mRNA as
already discussed by (Basu et al., 2005). When looking
at these results one can say that KLF1 appears to have a
greater effect on Eand Gglobin gene expression but with
KLF2 also plays an important role. The synergistic reg-
ulation of the human Eand Gglobin genes by KLF1 and
KLF2 in transgenic mice models cannot be ruled out.
ChiP assays were carried out to better understand the
mechanism by which KLF1 and KLF2 control human
and mouse embryonic B-globin gene expression. It was
found that at E10.5, KLF1was significantly enriched at
the promoters of the EGand Bh1-globin genes at mouse
5’HS2 in the LCR. KLF1 was significantly enriched at
the promoter of the G-globin gene, 5’HS2 and 5’HS3 in
human B-globin loci. The pattern of KLF1 enrichment
at the mouse and human B-globin loci at E11.5 was sim-
ilar as that at E10.5, the only difference being that the
binding of KLF1 to E-globin was also seen at E11.5.
KLF2 in contrast to KLF1 was detected at the EGbut
not at the Bh1-globin promoter at E11.5. This is consis-
tent with (Strouboulis et al., 1992) that at E11.5 there is
higher expression of the EGthan Bh1-globin gene. In the
mouse B-globin LCR there was no evidence that KLF2
binds to 5’HS2 and 5’HS3 but in human B-globin lo-
cus KLF2 was enhanced by about 2-fold at the G-globin
promoter and at 5’HS2 and 5HS3. These results by (Al-
hashem et al., 2011) show that by direct binding to the
CACCC elements in the promoters and LCR KLF1 and
KLF2 regulates the embryonic and foetal B-globin genes.
As in adult erythroid cells, binding of KLF1 and KLF2
to LCR could be necessary for direct contact between
the LCR and the B-globin gene promoter (Drissen et al.,
2004).
Figure 4: Schematic diagram of cross-regulation between
Klf1, Klf3 and Klf8. Klf1 activates expression of the Klf3 and
Klf8 gene promoters. Klf3 can also repress the Klf8 promoters.
In tissues where both Klf1 and Klf3 are present, such as foetal
liver, the proteins compete for binding, and this restricts Klf8 to
low levels of expression. In the absence of Klf3, for example in
the Klf3 null foetal liver, Klf1 gains access to the Klf8 promoters,
resulting in de-repression of the gene and increased Klf8 protein
(Adapted from (Eaton et al., 2008)).
8 Other Kruppel-like factors
Although some KLFs such as KLF1 primarily function
as activators of transcription (Miller and Bieker, 1993),
other KLFs such as KLF3 have been described as tran-
scriptional repressors (Turner and Crossley, 1998). On
the other hand KLF8 can act as either activator or re-
pressor depending on the biological context and the gene
regulatory region through which it is operating (van
Vilet et al., 2000; Wei et al., 2006; Urvalek et al., 2010;
Urvalek et al., 2011). It was documented (Funnell et al.,
2007; Eaton et al., 2008) by that the transcription of
KLF3 and KLF8 is carried out by KLF1 as showed in
figure 4.
KLF3 that was previously known as basic Kruppel-like
factor (BKLF) silences gene expression by the recruit-
ment of co-repressor C-terminal binding protein (CtBP)
(Turner and Crossley, 1998; Pearson et al., 2011). Al-
though KLF3 is expressed widely, since it has an ery-
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throid specific promoter that is directly activated by
KLF1, it is abundant in erythroid tissue (Tallack et al.,
2010; Funnell et al., 2007). In vitro, KLF3 exhibits sim-
ilar DNA-binding preferences to KLF1 and in erythroid
cells in vivo it is as though many genes that are acti-
vated by KLF1 are repressed by KLF3 to fine-tune their
expression during erythropoiesis (Funnell et al., 2012).
KLF8 is one such gene that is activated by KLF1 and re-
pressed by KLF3 (Eaton et al., 2008). KLF3 and KLF8
proteins share 96% of their sequence in their zinc fin-
ger domain (Lomberk and Urrutia, 2005) and both pro-
teins recruit CtBP corepressor to silence gene expression
(Turner and Crossley, 1998).
The erythroid roles of KLF1 and KLF3 were already
investigated but little was known about the contribution
of KLF8 to this regulatory network. Therefore Alister
et al., (2013) investigated the erythroid role of KLF8.
For this study KLF3-/- were crossed with mice with
homozygous disruption of KLF8 (KLF8gt/gt) followed
by histological examination of mice, quantitative real
time RT-PCR for KLF8, E-globin, Bh1-globin, ζ-globin
and α-globin. Protein overexpression in COS cells was
also performed followed by Western blotting, genotyp-
ing, ChIP analysis and microarrays. It was found by
(Lahiri and Zhao, 2012) that KLF8 protein is normally
expressed at very low levels in non-cancerous tissue, Al-
ister et al., (2013) noted that endogenous KLF8 was also
seen in wildtype foetal brain and placental tissue.
It was noted that mice deficient in KLF3 were also
viable, but KLF3-/-KLF8gt/gt double mutant died at
around E14.5. This shows that in vivo KLF3 and KLF8
have overlapping roles and they partially compensate
in each other’s absence. When KLF3-/- mice were an-
alyzed, KLF8 expression in several tissues was upreg-
ulated but this was also noted also in erythroid tissue.
Alister et al., (2013) hypothesized that KLF3 and KLF8
operate in a regulatory network to control gene expres-
sion since it is known that both of them are activated by
KLF1 (Eaton et al., 2008). This was confirmed by mi-
croarray analysis of Ter119+ foetal liver cells from single
mutant and double mutant embryos. In the absence of
KLF3, 64 genes were unregulated and these were not
significantly elevated in KLF3-/-KLF8gt/gt embryos.
By qRT-PCR Alister et al., (2013) confirmed that in
KLF3-/- and KLF3-/-KLF8gt/gt embryonic gene expres-
sion is derepressed but adult globin expression is un-
changed. This can be due to KLF3, which is the pri-
mary repressor of embryonic globin expression and in
its absence KLF8 is able to partially compensate. Alis-
ter et al., (2013) suggest that together KLF3 and KLF8
participate in the silencing of embryonic globins with
other repressors such as SOX6, GATA1, YY1, COUP-
TF and DRED (Stamatoyannopoulous, 2005; Tanabe
et al., 2002; Filipe et al., 1999; Tanimoto et al., 2000).
In Klf3−/− and KLF3−/−KLF8gt/gt, BCL11A expres-
sion was not found to be unchanged when compared
to wildtype. This implies that the repression of em-
bryonic globin genes by KLF3 and KLF8 is not indi-
rectly achieved by altering the transcription of these
known regulators in erythroid cells (Alister et al., 2013).
In Klf3−/− and KLF3−/−KLF8gt/gt it was also noted
that in addition to upregulation of the B-like embryonic
globins there was also unpregulation of Hba-x expres-
sion. Both KLF3 and KLF8 are a pair of transcription
regulators that operate in an erythroid transcriptional
network downstream of KLF1. The dominant role in
regulating gene expression is carried out by KLF3 while
KLF8 is able to partially compensate at some loci.
9 Conclusion
As seen in this review, KLFs are a family of DNA-
binding transcriptional regulators that are involved
in a wide range of biological processes. KLF1,
KLF10, KLF2, KLF3 and KLF8 are involved in
haemoglobin control. Trying to understand the com-
plex network between these transcription factors and
haemoglobin switching can be a fruitful approach to
raise therapeutic HbF levels in individuals with B-type
haemoglobinopathies treating the underlying dysery-
thropoiesis and associated complications.
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